|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/16 | |
| A61K 9/22 | |||
| A61K 31/195 | |||
| A61K 31/216 | |||
| A61K 45/06 | |||
| A61P 25/16 | |||
| A61K 9/24 |
| (11) | Patento numeris | 2515876 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10778748.3 |
| Europos patento paraiškos padavimo data | 2010-11-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-10-31 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-01-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/002937 |
| Data | 2010-11-08 |
| (87) | Numeris | WO 2011/056240 |
| Data | 2011-05-12 |
| (30) | Numeris | Data | Šalis |
| 259567 P | 2009-11-09 | US |
| (72) |
MAO, Chen, US
PARGAONKAR, Nikhil, US
MAURER, Laura E., US
MA, Sarina Grace Harris, US
|
| (73) |
XenoPort, Inc.,
3410 Central Expressway, Santa Clara, CA 95051,
US
|
| (54) | PHARMACEUTICAL COMPOSITIONS AND ORAL DOSAGE FORMS OF A LEVODOPA PRODRUG AND METHODS OF USE |
| PHARMACEUTICAL COMPOSITIONS AND ORAL DOSAGE FORMS OF A LEVODOPA PRODRUG AND METHODS OF USE |